Role of Ferroptosis in Lung Diseases

J Inflamm Res. 2021 May 20:14:2079-2090. doi: 10.2147/JIR.S307081. eCollection 2021.

Abstract

Ferroptosis is a new type of programmed cell death characterized by intracellular iron accumulation and lipid peroxidation that leads to oxidative stress and cell death. The metabolism of iron, lipids, and amino acids and multiple signalling pathways precisely regulate the process of ferroptosis. Emerging evidence has demonstrated that ferroptosis participates in the occurrence and progression of various pathological conditions and diseases, such as infections, neurodegeneration, tissue ischaemia-reperfusion injury and immune diseases. Recent studies have also indicated that ferroptosis plays a critical role in the pathogenesis of acute lung injury, chronic obstructive pulmonary disease, pulmonary fibrosis, pulmonary infection and asthma. Herein, we summarize the latest knowledge on the regulatory mechanism of ferroptosis and its association with iron, lipid and amino acid metabolism as well as several signalling pathways. Furthermore, we review the contribution of ferroptosis to the pathogenesis of lung diseases and discuss ferroptosis as a novel therapeutic target for various lung diseases.

Keywords: ferroptosis; lung diseases; metabolic networks and pathways; signalling pathways.

Publication types

  • Review

Grants and funding

This work was supported by the National Natural Science Foundation of China [grant numbers: 81871601, 82000085], the Development Fund for Anesthesiology by Shanghai Pulmonary Hospital (2021), the Young Elite Scientist Sponsorship Program by CAST (2018QNRC001), the Basic Research Program for Young Elite Scientist by Shanghai Association for the Study of Pain (2018SASP01), the Research Program for Young Scientist by Shanghai Society of Anesthesiology (2019SSA).